Rhumbline Advisers Applied Genetic Technologies Corp Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.62 - $5.23 $128,969 - $186,329	-35,627 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$3.94 - $8.19 $26,634 - $55,364	6,760 Added 23.42%	35,627 $181,000
Q4 2020 Feb 10, 2021	BUY	$3.99 - $5.7 $21,693 - $30,990	5,437 Added 23.21%	28,867 $118,000
Q3 2020 Nov 12, 2020	SELL	$4.38 - $6.43 $21,440 - $31,474	-4,895 Reduced 17.28%	23,430 $114,000
Q2 2020 Aug 13, 2020	BUY	$3.0 - $6.9 $84,975 - $195,442	28,325 New	28,325 $157,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.